Your browser doesn't support javascript.
loading
Societal economic burden of hypertension at selected hospitals in southern Ethiopia: a patient-level analysis.
Sorato, Mende Mensa; Davari, Majid; Kebriaeezadeh, Abbas; Sarrafzadegan, Nizal; Shibru, Tamiru.
Afiliación
  • Sorato MM; Department of Pharmacy, Arba Minch University, Arba Minch, Ethiopia mendemensa@gmail.com.
  • Davari M; Faculty of Pharmacy, Department of Pharmacoeconomics and Pharmaceutical Administration, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of).
  • Kebriaeezadeh A; Faculty of Pharmacy, Department of Pharmacoeconomics and Pharmaceutical Administration, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of).
  • Sarrafzadegan N; Faculty of Pharmacy, Department of Pharmacoeconomics and Pharmaceutical Administration, Tehran University of Medical Sciences School of Pharmacy, Tehran, Iran (the Islamic Republic of).
  • Shibru T; Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences, Isfahan, Iran (the Islamic Republic of).
BMJ Open ; 12(4): e056627, 2022 04 06.
Article en En | MEDLINE | ID: mdl-35387822
ABSTRACT

OBJECTIVES:

There is inadequate information on the economic burden of hypertension treatment in Ethiopia. Therefore, this study was conducted to determine the societal economic burden of hypertension at selected hospitals in Southern Ethiopia.

METHODS:

Prevalence-based cost of illness study from a societal perspective was conducted. Disability-adjusted life years (DALYs) were determined by the current WHO's recommended DALY valuation method. Adjustment for comorbidity and a 3% discount was done for DALYs. The data entry, processing and analysis were done by using SPSS V.21.0 and Microsoft Excel V.2013.

RESULTS:

We followed a cohort of 406 adult patients with hypertension retrospectively for 10 years from September 2010 to 2020. Two hundred and fifty (61.6%) of patients were women with a mean age of 55.87±11.03 years. Less than 1 in five 75 (18.5%) of patients achieved their blood pressure control target. A total of US$64 837.48 direct cost was incurred due to hypertension. A total of 11 585 years and 579.57 years were lost due to hypertension-related premature mortality and morbidity, respectively. Treated and uncontrolled hypertension accounted for 50.83% (6027) of total years lost due to premature mortality from treated hypertension cohort. Total productivity loss due to premature mortality and morbidity was US$449 394.69. The overall economic burden of hypertension was US$514 232.16 (US$105.55 per person per month).

CONCLUSION:

Societal economic burden of hypertension in Southern Ethiopia was substantial. Indirect costs accounted for more than 8 out of 10 dollars. Treated and uncontrolled hypertension took the lion's share of economic cost and productivity loss due to premature mortality and morbidity. Therefore, designing and implanting strategies for the prevention of hypertension, early screening and detection, and improving the rate of blood pressure control by involving all relevant stakeholders at all levels is critical to saving scarce health resources.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Estrés Financiero / Hipertensión Tipo de estudio: Health_economic_evaluation / Observational_studies / Risk_factors_studies País/Región como asunto: Africa Idioma: En Revista: BMJ Open Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Estrés Financiero / Hipertensión Tipo de estudio: Health_economic_evaluation / Observational_studies / Risk_factors_studies País/Región como asunto: Africa Idioma: En Revista: BMJ Open Año: 2022 Tipo del documento: Article